Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G47delta for progressive olfactory neuroblastoma
jRCTs033180325Active, not recruiting
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Sep 2013
- Modality
- Oncolytic Viruses → Oncolytic Therapeutics, Gene Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of teserpaturev in esthesioneuroblastoma (ENB), sponsored by Japan Agency for Medical Research and Development. Primary endpoint: Safety. Started Sep 2013; status: active, not recruiting.
02
Drugs
teserpaturev
03
Conditions
esthesioneuroblastoma (ENB)
Beyond the preview
Go deeper on jRCTs033180325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs033180325.